1 Study Coverage
1.1 Oral Cholera Vaccine Product Introduction
1.2 Market Segments
1.3 Key Oral Cholera Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Cholera Vaccine Market Size Growth Rate by Type
1.4.2 Shanchol
1.4.3 Dukoral
1.4.4 Vaxchora
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Cholera Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research & Academic Laboratories
1.5.4 Pharmaceutical & Biotechnology Companies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Cholera Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Oral Cholera Vaccine Revenue 2015-2026
2.1.2 Global Oral Cholera Vaccine Sales 2015-2026
2.2 Global Oral Cholera Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Cholera Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Cholera Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Cholera Vaccine Competitor Landscape by Players
3.1 Oral Cholera Vaccine Sales by Manufacturers
3.1.1 Oral Cholera Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Oral Cholera Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Cholera Vaccine Revenue by Manufacturers
3.2.1 Oral Cholera Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Oral Cholera Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Cholera Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Cholera Vaccine Revenue in 2019
3.2.5 Global Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Cholera Vaccine Price by Manufacturers
3.4 Oral Cholera Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Oral Cholera Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Cholera Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Oral Cholera Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Cholera Vaccine Market Size by Type (2015-2020)
4.1.1 Global Oral Cholera Vaccine Sales by Type (2015-2020)
4.1.2 Global Oral Cholera Vaccine Revenue by Type (2015-2020)
4.1.3 Oral Cholera Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Cholera Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Cholera Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Cholera Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Oral Cholera Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Cholera Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oral Cholera Vaccine Market Size by Application (2015-2020)
5.1.1 Global Oral Cholera Vaccine Sales by Application (2015-2020)
5.1.2 Global Oral Cholera Vaccine Revenue by Application (2015-2020)
5.1.3 Oral Cholera Vaccine Price by Application (2015-2020)
5.2 Oral Cholera Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Cholera Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Cholera Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Cholera Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Cholera Vaccine by Country
6.1.1 North America Oral Cholera Vaccine Sales by Country
6.1.2 North America Oral Cholera Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Cholera Vaccine Market Facts & Figures by Type
6.3 North America Oral Cholera Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Cholera Vaccine by Country
7.1.1 Europe Oral Cholera Vaccine Sales by Country
7.1.2 Europe Oral Cholera Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Cholera Vaccine Market Facts & Figures by Type
7.3 Europe Oral Cholera Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Cholera Vaccine by Region
8.1.1 Asia Pacific Oral Cholera Vaccine Sales by Region
8.1.2 Asia Pacific Oral Cholera Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Cholera Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Oral Cholera Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Cholera Vaccine by Country
9.1.1 Latin America Oral Cholera Vaccine Sales by Country
9.1.2 Latin America Oral Cholera Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Cholera Vaccine Market Facts & Figures by Type
9.3 Central & South America Oral Cholera Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Cholera Vaccine by Country
10.1.1 Middle East and Africa Oral Cholera Vaccine Sales by Country
10.1.2 Middle East and Africa Oral Cholera Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Cholera Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Oral Cholera Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 PaxVax
11.1.1 PaxVax Corporation Information
11.1.2 PaxVax Description and Business Overview
11.1.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
11.1.4 PaxVax Oral Cholera Vaccine Products Offered
11.1.5 PaxVax Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Oral Cholera Vaccine Products Offered
11.2.5 Sanofi Related Developments
11.3 Valneva
11.3.1 Valneva Corporation Information
11.3.2 Valneva Description and Business Overview
11.3.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Valneva Oral Cholera Vaccine Products Offered
11.3.5 Valneva Related Developments
11.4 EuBiologics
11.4.1 EuBiologics Corporation Information
11.4.2 EuBiologics Description and Business Overview
11.4.3 EuBiologics Sales, Revenue and Gross Margin (2015-2020)
11.4.4 EuBiologics Oral Cholera Vaccine Products Offered
11.4.5 EuBiologics Related Developments
11.1 PaxVax
11.1.1 PaxVax Corporation Information
11.1.2 PaxVax Description and Business Overview
11.1.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
11.1.4 PaxVax Oral Cholera Vaccine Products Offered
11.1.5 PaxVax Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Cholera Vaccine Market Estimates and Projections by Region
12.1.1 Global Oral Cholera Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Cholera Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Oral Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Cholera Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Cholera Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Cholera Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Cholera Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Cholera Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Cholera Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Cholera Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Cholera Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
PaxVax、Sanofi、Valneva、EuBiologics
【免責事項】
https://www.globalresearch.jp/disclaimer